10-K/A: Benson Hill Files Amended 10-K Report Including Part III Information and Updated Certifications

Sentiment:

Annual Report Amendment


Benson Hill, Inc. has filed an amendment to its annual report on Form 10-K to include previously omitted information and updated certifications.

Delay expectedThe company is filing this amendment because a definitive proxy statement containing the required information may not be filed within 120 days after the fiscal year-end.

Summary

  • Benson Hill, Inc. filed an amendment to its annual report on Form 10-K, designated as Amendment No. 1, to include information required by Items 10 through 14 of Part III of Form 10-K.
  • This amendment restates Part III, Items 10 through 14 in their entirety and includes updated certifications pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
  • The original 10-K was filed on March 15, 2024, and this amendment was filed because a definitive proxy statement containing the Part III information may not be filed within 120 days after the fiscal year-end.
  • The amendment does not include new financial statements or modify disclosures related to Items 307 and 308 of Regulation S-K.
  • The document provides detailed information on the company's directors, executive officers, corporate governance, executive compensation, security ownership, related transactions, and accounting fees.

Sentiment

Score: 7

Explanation: The document is primarily factual and descriptive, with no strong positive or negative sentiment. The changes in executive leadership and the need for an amendment are slightly negative, but the overall tone is neutral and professional.

Positives

  • The company has a diverse and experienced board of directors with expertise in various sectors.
  • The company has established corporate governance guidelines and committees to ensure proper oversight.
  • The company has implemented various policies to promote good corporate governance, including insider trading, anti-hedging, and clawback policies.
  • The company has a comprehensive executive compensation program that includes base salary, bonuses, and equity awards.

Negatives

  • The company had a change in CEO, with Matthew B. Crisp resigning on June 15, 2023, and Adrienne Elsner taking over.
  • There was a change in CFO, with Dean Freeman's employment terminated on March 29, 2024.
  • The company's stock price has not yet met certain performance targets for vesting of some equity awards.
  • The company has incurred significant expenses related to executive transitions and consulting agreements.

Risks

  • The company faces risks related to economic, operational, financial, competitive, legal, technical, scientific, regulatory, cybersecurity, privacy, compliance, and reputational issues.
  • The company's compensation policies and programs could potentially encourage excessive risk-taking.
  • The company's ability to achieve performance targets for equity awards is subject to market conditions and other factors.
  • The company's financial performance is subject to various risks, including those related to tax matters, litigation, financial instruments, and information security.

Future Outlook

The document does not contain specific forward-looking statements, but it does outline the company's ongoing compensation and incentive programs.

Management Comments

  • The Board believes that the current formation of our Board is the best leadership structure for us at the current time and is in the best interests of our Company and stockholders.
  • Our Board has adopted Corporate Governance Guidelines that set forth expectations for directors, director independence standards, board committee structure and functions and other policies for the governance of our Company.

Industry Context

This filing provides transparency into Benson Hill's corporate governance and executive compensation practices, which are important for investors in the agricultural technology sector. The company's focus on innovation and sustainability aligns with broader industry trends.

Comparison to Industry Standards

  • The company's board composition and committee structure are consistent with best practices for publicly traded companies.
  • The executive compensation packages are competitive with those of other companies in the ag-tech and biotech sectors.
  • The company's corporate governance policies, including insider trading and clawback policies, are in line with industry standards.
  • The company's use of equity-based compensation is a common practice to align executive interests with those of shareholders.
  • The company's audit and risk committee structure and responsibilities are consistent with SEC and NYSE requirements.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chief Executive OfficerMatthew B. CrispAdrienne ElsnerOctober 31, 2023Resignation of previous CEO and appointment of new CEO
Chief Financial OfficerDean FreemanSusan KeefeMarch 2024Termination of previous CFO and appointment of new CFO

Stakeholder Impact

  • Shareholders will receive more complete information about the company's governance and compensation practices.
  • Employees will be affected by changes in executive leadership and compensation programs.
  • Customers and suppliers may be indirectly affected by changes in the company's strategy and operations.

Next Steps

  • The company will continue to operate under its established corporate governance and compensation programs.
  • The company will likely file a definitive proxy statement in the future.
  • The company will continue to monitor and manage its risks and opportunities.

Key Dates

DateDescription
March 15, 2024Original 10-K filing date.
April 15, 2024Date of director and executive officer information, and share count.
April 26, 2024Date of the amended 10-K/A filing and certifications.

Keywords

corporate governance, executive compensation, board of directors, financial reporting, stock ownership, Sarbanes-Oxley Act, risk management, equity awards, audit committee, chief executive officer, chief financial officer

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.